Who
Sharad Mansukani
Director
Company insider
Files Form 4 as: Director, agilon health; Director, Convey Health Solutions Holdings; Director, Endo International; Director, Kindred Healthcare; Director, Surgical Care Affiliates; Director, IMS Health Holdings; EVP - Chief Strategy Officer, HealthSpring.
In numbers
- Trades disclosed
- 55
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $7.3M
- Companies
- 7
- Companies where not an officer
- 6
- First trade
- 6 Jun 2007
- Last trade
- 2 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jun 2026filed 4 Jun 2026 | AGL agilon healthProviders & Facilities | SEC FORM 4 Code A | —2,133 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | AGL agilon healthProviders & Facilities | SEC FORM 4 Code A | —2,133 at $0.00 | filing |
| 28 May 2025filed 30 May 2025 | AGL agilon healthProviders & Facilities | SEC FORM 4 Code A | —78,724 at $0.00 | filing |
| 29 May 2024filed 31 May 2024 | AGL agilon healthProviders & Facilities | SEC FORM 4 Code A | —32,119 at $0.00 | filing |
| 14 Apr 2023filed 18 Apr 2023 | AGL agilon healthProviders & Facilities | SEC FORM 4 Code A | —5,622 at $0.00 | filing |
| 7 Oct 2022filed 12 Oct 2022 | Convey Health Solutions Holdingsoption or derivative | SEC FORM 4 Code D | —235,935 | filing |
| 7 Oct 2022filed 12 Oct 2022 | Convey Health Solutions Holdingsoption or derivative | SEC FORM 4 Code D | —438,165 | filing |
| 7 Oct 2022filed 12 Oct 2022 | Convey Health Solutions Holdingsoption or derivative | SEC FORM 4 Code D | —54,250 | filing |
| 14 Apr 2022filed 20 Apr 2022 | AGL agilon healthProviders & Facilities | SEC FORM 4 Code A | —6,936 at $0.00 | filing |
| 28 Mar 2022filed 30 Mar 2022 | Convey Health Solutions Holdingsoption or derivative | SEC FORM 4 Code A | —54,250 at $0.00 | filing |
| 14 Sep 2021filed 15 Sep 2021 | AGL agilon healthoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —156,250 at $0.00 | filing |
| 14 Sep 2021filed 15 Sep 2021 | AGL agilon healthProviders & Facilities | SEC FORM 4 Code M | $156K156,250 at $1.00 | filing |
| 14 Sep 2021filed 15 Sep 2021 | AGL agilon healthProviders & Facilities | SEC FORM 4 Sold | $4.5M156,250 at $28.98 | filing |
| 14 Apr 2021filed 16 Apr 2021 | AGL agilon healthProviders & Facilities | SEC FORM 4 Code A | —6,956 at $0.00 | filing |
| 12 Jun 2019filed 14 Jun 2019 | Endo International | SEC FORM 4 Code A | —53,812 at $0.00 | filing |
| 12 Jun 2019filed 14 Jun 2019 | Endo International | SEC FORM 4 Code F | $115K25,829 at $4.46 | filing |
| 2 Jul 2018filed 2 Jul 2018 | Kindred Healthcare | SEC FORM 4 Code D | $347K38,512 at $9.00 | filing |
| 8 Jun 2018filed 12 Jun 2018 | Endo International | SEC FORM 4 Code A | —31,291 at $0.00 | filing |
| 8 Jun 2018filed 12 Jun 2018 | Endo International | SEC FORM 4 Code F | $115K15,019 at $7.67 | filing |
| 8 Nov 2017filed 13 Nov 2017 | Endo International | SEC FORM 4 Code A | —6,681 at $0.00 | filing |
News
Analyzing Agilon Health (NYSE:AGL) and Fulgent Genetics (NASDAQ:FLGT)AGL · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Sharad Mansukani; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.